| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/26/2009 | US20090081280 Compositions and methods for modulating hemostasis |
| 03/26/2009 | US20090081278 Drug Delivery System |
| 03/26/2009 | US20090081275 Durable swellable hydrogel matrix and methods |
| 03/26/2009 | US20090081274 Mast cell-derived renin |
| 03/26/2009 | US20090081265 Highly porous, recognitive polymer systems |
| 03/26/2009 | US20090081263 Double-stranded rna oligonucleotides which inhibit tyrosinase expression |
| 03/26/2009 | US20090081262 Metal oxide coating of water insoluble ingredients |
| 03/26/2009 | US20090081254 Hiv vaccine for mucosal delivery |
| 03/26/2009 | US20090081139 Water-based delivery systems |
| 03/26/2009 | US20090081131 Tumor therapy with high affinity laminin receptor-targeted vectors and compounds |
| 03/26/2009 | US20090081130 Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream |
| 03/26/2009 | US20090081122 Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant |
| 03/26/2009 | DE102007043776A1 Verwendung von Mikrokapseln und Mikrokapseln Use of the microcapsules and microcapsules |
| 03/26/2009 | CA2737786A1 Microcapsules and methods |
| 03/26/2009 | CA2700224A1 Method of producing granules containing natural products derived substance such as chinese orthodox medicine extracts, crude drug extracts, and extracts derived from natural substances, and producing a tablet in use of said granules |
| 03/26/2009 | CA2700072A1 Steroid containing ophthalmic drug delivery systems |
| 03/26/2009 | CA2699868A1 Biocompatible foams, systems, and methods |
| 03/26/2009 | CA2699806A1 Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine |
| 03/26/2009 | CA2699802A1 Aqueous-core lipid nanocapsules for encapsulating hydrophilic and/or lipophilic molecules |
| 03/26/2009 | CA2699761A1 Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same |
| 03/26/2009 | CA2699266A1 Drug delivery system |
| 03/26/2009 | CA2699227A1 Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol |
| 03/26/2009 | CA2699224A1 Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol |
| 03/26/2009 | CA2697938A1 Dip coated compositions containing copolymer of polyvinyl alcohol and polyethylene glycol and a gum |
| 03/26/2009 | CA2696914A1 Lyophilized pharmaceutical compositions |
| 03/26/2009 | CA2695435A1 Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease |
| 03/26/2009 | CA2693912A1 System for controlled release of an active principle and method for preparation |
| 03/25/2009 | EP2039700A2 Novel anti-inflammatory androstane derivatives |
| 03/25/2009 | EP2039421A1 Refining apparatus |
| 03/25/2009 | EP2039370A1 Ophthalmic composition for soft contact lens comprising terpenoid |
| 03/25/2009 | EP2039358A1 Pharmaceutical compositions comprising a macrolide and an acid |
| 03/25/2009 | EP2039353A1 Reduced coenzyme q10-containing composition and method for producing the same |
| 03/25/2009 | EP2039352A1 Aqueous-core lipid nanocapsules for encapsulating hydrophilic and/or lipophilic molecules |
| 03/25/2009 | EP2039351A1 Method for producing free-flowing, powder-form extracts with the help of fluidised bed drying |
| 03/25/2009 | EP2039350A1 Method of separating vesicle, process for producing medicinal preparation, and method of evaluation |
| 03/25/2009 | EP2039349A1 Solid pharmaceutical composition comprising donepezil hydrochloride |
| 03/25/2009 | EP2039255A1 Formulae for dietary supplements and solid sweet luxury foodstuffs which dissolve in the mouth |
| 03/25/2009 | EP2039254A1 Hybrid inducible release vehicle |
| 03/25/2009 | EP2038325A1 Polyurethane elastomers |
| 03/25/2009 | EP2037941A1 Cobalamin compositions and methods for treating or preventing mucositis |
| 03/25/2009 | EP2037938A2 Drug delivery polymer with hydrochloride salt of clindamycin |
| 03/25/2009 | EP2037921A2 Sugar-free storage-stable antihistaminic syrups |
| 03/25/2009 | EP2037918A2 Pharmaceutical formulations of pimavanserin |
| 03/25/2009 | EP2037914A1 A suspension comprising benzimidazole carbamate and a polysorbate |
| 03/25/2009 | EP2037909A2 Solid dose formulations of a thrombin receptor antagonist |
| 03/25/2009 | EP2037899A2 Nanoparticles for nucleic acid delivery |
| 03/25/2009 | EP2037898A2 Ibuprofen-containing liquid filled hard capsules |
| 03/25/2009 | EP2037897A2 An oral pharmaceutical composition of an anilinopyrimidine, its preparation and use thereof |
| 03/25/2009 | EP2037896A1 Effervescent granules or granular material |
| 03/25/2009 | EP2037895A1 Xylitol troches and methods of use |
| 03/25/2009 | EP2037894A2 Compositions with controlled pharmacokinetics |
| 03/25/2009 | EP2037893A2 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 03/25/2009 | EP2037891A1 Tablets comprising candesartan cilexetil |
| 03/25/2009 | EP2037890A1 Oral pharmaceutical composition of a poorly water-soluble active substance |
| 03/25/2009 | EP2037889A2 Nanostructured lipid carriers containing riluzole and pharmaceutical formulations containing said particles |
| 03/25/2009 | EP2037888A2 Active agent formulations, methods of making, and methods of use |
| 03/25/2009 | EP2037887A2 Oral controlled release formulations of an interleukin-1 beta converting enzyme inhibitor |
| 03/25/2009 | EP2037886A1 Controlled crystallization of powders |
| 03/25/2009 | EP2037885A1 Low dose sublingual tablets of opioid analgesics and preparation process |
| 03/25/2009 | EP2037884A2 Sustained release formulations of aromatase inhibitors |
| 03/25/2009 | EP2037883A2 Inhalant powder containing phenylalanine |
| 03/25/2009 | EP2037881A1 Steroid-containing sustained release intraocular implants and related methods |
| 03/25/2009 | EP2037880A2 Compositions and methods for treating conditions of the nail unit |
| 03/25/2009 | EP2037879A1 Compositions of glycopyrronium salt for inhalation |
| 03/25/2009 | EP2000152A9 Solid preparation having improved solubility |
| 03/25/2009 | EP2000150A9 Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle |
| 03/25/2009 | EP1718258B1 Abuse resistance opioid transdermal delivery device |
| 03/25/2009 | EP1682080B1 Chewing gum for the remineralisation of tooth enamel |
| 03/25/2009 | EP1668062B1 Telechelic homopolyamino acids functionalized by hydrophobic groups and uses, particularly therapeutic, thereof |
| 03/25/2009 | EP1594471B1 Process for manufacturing a dexamethasone-containing formulation for oral administration |
| 03/25/2009 | EP1583713B1 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 03/25/2009 | EP1543063B1 Drug delivery |
| 03/25/2009 | EP1509201B1 Film-shaped preparations with improved chemical stability containing active substances and method for the production thereof |
| 03/25/2009 | EP1154770B1 Parenteral formulation of piperacillin |
| 03/25/2009 | EP1119335B1 Capsules and a process for making the same |
| 03/25/2009 | EP1053010B1 Copolymer compositions for oral delivery |
| 03/25/2009 | EP1050301B1 Medicinal compositions containing 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol |
| 03/25/2009 | CN201211389Y Chemical reaction vapor pressure type intestines and stomach drug releasing device suitable for ultrasonic trigger control |
| 03/25/2009 | CN101394898A Glucan compositions |
| 03/25/2009 | CN101394850A Orodispersible domperidone tablets |
| 03/25/2009 | CN101394842A Alpha protogen capsule composite stable in water phase and method for preparing the composite |
| 03/25/2009 | CN101394841A Fast-acting oral peptide pharmaceutical products |
| 03/25/2009 | CN101394840A Crush-resistant oxycodone tablets intended for preventing accidental misuse and unlawful diversion |
| 03/25/2009 | CN101394839A Crush-resistant oxycodone tablets intended for preventing accidental misuse and unlawful diversion |
| 03/25/2009 | CN101394838A Tablet formulations and processes |
| 03/25/2009 | CN101394837A Ezetimibe compositions |
| 03/25/2009 | CN101394836A Medicament containing fluoroquinolones |
| 03/25/2009 | CN101394835A Nebulizer formulation and production method thereof |
| 03/25/2009 | CN101394834A Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissues |
| 03/25/2009 | CN101392239A Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 03/25/2009 | CN101391103A Medicine composition for preventing and treating AIDS viral infection |
| 03/25/2009 | CN101391099A Use of growth hormone releasing peptides sustained release preparation in promoting fur-bearing animal grow |
| 03/25/2009 | CN101391098A Apitoxin liposome preparation and preparation method thereof |
| 03/25/2009 | CN101391073A Da huoluo capsule preparation method |
| 03/25/2009 | CN101391072A Traditional Chinese medicine for treating diabetic diarrhea |
| 03/25/2009 | CN101391053A Traditional Chinese medicine composition for treating hemorrhoid |
| 03/25/2009 | CN101391052A Traditional Chinese medicine composition for treating cerebral arteries emphraxis |
| 03/25/2009 | CN101391050A Traditional Chinese medicine capsule for treating cervical-shoulder disease |
| 03/25/2009 | CN101391046A Antalgic traditional Chinese medicine compound preparation and preparation method thereof |
| 03/25/2009 | CN101391045A Traditional Chinese medicine compound preparation for treating migraine and general headache and preparation method thereof |